Navigation Links
Jazz Pharmaceuticals to Present at Investor Conferences
Date:11/4/2008

PALO ALTO, Calif., Nov. 4 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that the company will present at three upcoming investor conferences.

On Tuesday, November 11, 2008 at 2:50 p.m. EST, Dr. Samuel R. Saks, Jazz Pharmaceuticals' CEO, will provide a corporate presentation at the Rodman & Renshaw 10th Annual Healthcare Conference in New York City.

On Wednesday, November 12, 2008 at 3:30 p.m. MST (5:30 p.m. EST), Dr. Saks will provide a corporate presentation at the Credit Suisse Healthcare Conference in Phoenix.

On Wednesday, November 19, 2008 at 11:30 a.m. EST, Robert M. Myers, President of Jazz Pharmaceuticals, will provide a corporate presentation at the Lazard Capital Markets 5th Annual Healthcare Conference in New York City.

A live webcast of these presentations may be accessed by visiting the Investors section of the Jazz Pharmaceuticals website at http://www.JazzPharmaceuticals.com. A replay will be available on the site for two weeks following each presentation.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.


'/>"/>
SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Rib-X Pharmaceuticals, Inc. to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
2. Trubion Pharmaceuticals Provides Announcement Dates for Third-Quarter and Nine Months Earnings Conference Call
3. MiddleBrook Pharmaceuticals Retains National Account Firm VCG & Associates
4. Pacira Pharmaceuticals Leverages TalentManager(R) from Salary.Com(TM) to Integrate Compensation and Performance Management Processes
5. Genesis Pharmaceuticals Files Counter Claims
6. Arena Pharmaceuticals Announces Third Quarter 2008 Financial Results
7. Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update
8. MiddleBrook Pharmaceuticals Schedules Conference Call and Webcast for Third Quarter 2008 Financial Results
9. ISTA Pharmaceuticals Reports Third Quarter 2008 Financial Results
10. ADVENTRX Pharmaceuticals to Report Third Quarter 2008 Results
11. Onyx Pharmaceuticals Announces Third Quarter 2008 Financial Results Teleconference and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... ... The threat of nuclear warfare has long plagued this world. In July ... testing of nuclear weapons. Years later, when her co-workers began dying, Dot started searching ... Testing,” Clayton exposes the critical decisions made by agencies involved in the nuclear testing ...
(Date:2/27/2017)... , ... February 27, 2017 , ... POUGHKEEPSIE, N. Y. ... has disclosed that despite scientific studies, the Center for Disease Control ( CDC ) ... disease . Kenneth B. Liegner, M.D. has compiled into a single volume a ...
(Date:2/27/2017)... ... 2017 , ... New Jersey ranks among the top five states in the ... need for advanced services is growing. , Project WE vs C is a ... with their non-profit partners in their fight against cancer and in support of their ...
(Date:2/26/2017)... York, New York (PRWEB) , ... February 26, ... ... luxury baby products for wholesale distribution in North America, today announced it would ... online sites. The company, which prides itself on crafting quality and unique baby ...
(Date:2/26/2017)... ... February 26, 2017 , ... Occupational pesticide exposure is linked ... LRRK2 mutation, according to a study released today at the 1st Pan American ... link between pesticides and incidence of sporadic PD through occupational exposure. This latest ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Australien, 24. Februar 2017 ... diversifiziertes Unternehmen des Gesundheitsbereiches, ist erfreut, für das ... mit dem entsprechenden Vorjahreszeitraum exzellente Ergebnisse vorlegen zu ... und Aktualisierung zum Wachstum" finden Sie hier ... Gewinn nach Steuern 2,12 Millionen USD (Dez. 2015: 1,04 Millionen USD; ...
(Date:2/24/2017)... 2017  Directors from Pharma To Market Pty Ltd and Ador ... resulting in the founding of Pharma To Market Pte Ltd, based ... are pleased to announce their expansion into Asia ... . The company are delighted to appoint Joelle Chia ... Singapore based entity. Joelle brings with her an ...
(Date:2/24/2017)... , Feb. 23, 2017 ... insights on the various drugs being developed ... covers all the drugs that are in ... Clinical). The pipeline focuses on novel pharmacologic ... antibodies, stem cell therapies, recombinant proteins and ...
Breaking Medicine Technology: